Compare RIV & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RIV | NUS |
|---|---|---|
| Founded | 2015 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.7M | 343.1M |
| IPO Year | N/A | 1996 |
| Metric | RIV | NUS |
|---|---|---|
| Price | $11.35 | $7.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 70.4K | ★ 415.5K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | ★ 12.85% | 3.19% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | N/A | ★ 3.18 |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.14 |
| P/E Ratio | ★ N/A | $2.36 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $10.23 | $5.32 |
| 52 Week High | $12.56 | $14.62 |
| Indicator | RIV | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 46.56 | 38.28 |
| Support Level | $10.98 | $7.02 |
| Resistance Level | $11.80 | $10.90 |
| Average True Range (ATR) | 0.20 | 0.22 |
| MACD | 0.04 | 0.11 |
| Stochastic Oscillator | 74.52 | 47.27 |
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.